|

NK cell preparation Clinical Trials

1 actively recruiting trial

Also known as: CEL001 injection

Pipeline

Phase 1: 1

Top Sponsors

  • Guangzhou Xiling Biotechnology Co., Ltd.1

Indications

  • Advanced Solid Tumors (Phase 1)1
  • Cancer1

Other1 trial

Safety and Tolerability Evaluation of CEL001 Injection in Advanced Solid Tumors
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.